Bogle Investment Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,543
Closed -$576K 74
2020
Q4
$576K Sell
10,543
-51,569
-83% -$2.71M 0.91% 31
2020
Q3
$3.11M Sell
62,112
-35,989
-37% -$1.71M 0.91% 44
2020
Q2
$3.75M Buy
+98,101
New +$3.15M 0.62% 65
2019
Q4
Sell
-21,854
Closed -$929K 299
2019
Q3
$929K Buy
+21,854
New +$917K 0.08% 182
2016
Q4
Sell
-212,910
Closed -$13.8M 382
2016
Q3
$13.8M Buy
+212,910
New +$12M 0.99% 16
2014
Q2
Sell
-167,499
Closed -$13.9M 365
2014
Q1
$13.9M Buy
167,499
+68,647
+69% +$6.03M 0.95% 8
2013
Q4
$13.7M Buy
98,852
+23,754
+32% +$2.8M 1.15% 7
2013
Q3
$7.19M Buy
75,098
+24,200
+48% +$2.05M 0.73% 40
2013
Q2
$3.11M Buy
+50,898
New +$2.83M 0.38% 107

Other funds holding NUS

Bogle Investment Management's NUS Position: Q1 2021 in Review

Bogle Investment Management sold out of Nu Skin (NUS) in Q1 2021, closing a stake of 10,543 shares — an estimated $576K sold.

Bogle Investment Management first reported a position in NUS in Q2 2013 and held it in 9 quarters. The position peaked at $13.9M in Q1 2014. 276 funds tracked by Wall St. Rank hold NUS as of Q1 2021.

  • Bogle Investment Management reported no remaining Nu Skin position as of Q1 2021 after selling out during the quarter.
  • Bogle Investment Management sold 10,543 Nu Skin shares in Q1 2021, an estimated $576K.
  • Bogle Investment Management first reported a position in Nu Skin in Q2 2013 and held it in 9 quarters.
  • Bogle Investment Management's Nu Skin position peaked at $13.9M in Q1 2014.
  • 276 funds tracked by Wall St. Rank held Nu Skin as of Q1 2021.

Based on Bogle Investment Management's 13F filing for Q1 2021.